UPDATE 1-Fresenius net profit up 24 percent on generic intravenous drugs

* FMC Q1 net income up 9 pct on higher U.S. reimbursement (Adds details on intravenous drugs unit Kabi, FMC anaemia drug)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.